Structure

Physi-Chem Properties

Molecular Weight:  414.17
Volume:  421.135
LogP:  5.586
LogD:  2.684
LogS:  -3.942
# Rotatable Bonds:  5
TPSA:  128.2
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.428
Synthetic Accessibility Score:  3.702
Fsp3:  0.391
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.046
MDCK Permeability:  1.057509689417202e-05
Pgp-inhibitor:  0.209
Pgp-substrate:  0.011
Human Intestinal Absorption (HIA):  0.269
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.005
Plasma Protein Binding (PPB):  97.85071563720703%
Volume Distribution (VD):  0.424
Pgp-substrate:  1.9173672199249268%

ADMET: Metabolism

CYP1A2-inhibitor:  0.626
CYP1A2-substrate:  0.908
CYP2C19-inhibitor:  0.156
CYP2C19-substrate:  0.252
CYP2C9-inhibitor:  0.821
CYP2C9-substrate:  0.609
CYP2D6-inhibitor:  0.016
CYP2D6-substrate:  0.166
CYP3A4-inhibitor:  0.092
CYP3A4-substrate:  0.199

ADMET: Excretion

Clearance (CL):  4.753
Half-life (T1/2):  0.085

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.184
Drug-inuced Liver Injury (DILI):  0.987
AMES Toxicity:  0.548
Rat Oral Acute Toxicity:  0.158
Maximum Recommended Daily Dose:  0.297
Skin Sensitization:  0.847
Carcinogencity:  0.183
Eye Corrosion:  0.003
Eye Irritation:  0.491
Respiratory Toxicity:  0.151

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC226942

Natural Product ID:  NPC226942
Common Name*:   (2S)-2-Methyl-1-[1,3,7,9-Tetrahydroxy-2,8-Dimethyl-6-(2-Methylpropanoyl)Dibenzofuran-4-Yl]Butan-1-One
IUPAC Name:   (2S)-2-methyl-1-[1,3,7,9-tetrahydroxy-2,8-dimethyl-6-(2-methylpropanoyl)dibenzofuran-4-yl]butan-1-one
Synonyms:  
Standard InCHIKey:  SIPJAOYDFTWIRY-VIFPVBQESA-N
Standard InCHI:  InChI=1S/C23H26O7/c1-7-9(4)17(25)15-21(29)11(6)19(27)13-12-18(26)10(5)20(28)14(16(24)8(2)3)22(12)30-23(13)15/h8-9,26-29H,7H2,1-6H3/t9-/m0/s1
SMILES:  CC[C@@H](C(=O)c1c(O)c(C)c(c2c1oc1c2c(O)c(c(c1C(=O)C(C)C)O)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2146931
PubChem CID:   71461795
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000301] Benzofurans
        • [CHEMONTID:0000015] Dibenzofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32572 pilidostigma glabrum Species n.a. n.a. n.a. Australian n.a. PMID[22934671]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 4400.0 nM PMID[532996]
NPT886 Cell Line NIH3T3 Mus musculus IC50 > 200000.0 nM PMID[532996]
NPT113 Cell Line RAW264.7 Mus musculus ED50 = 17.6 uM PMID[532996]
NPT886 Cell Line NIH3T3 Mus musculus ED50 = 22.3 uM PMID[532996]
NPT113 Cell Line RAW264.7 Mus musculus Selectivity Index = 4.0 n.a. PMID[532996]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 12100.0 nM PMID[532996]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 24.1 uM PMID[532996]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 6000.0 nM PMID[532996]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 6000.0 nM PMID[532996]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MBC = 6.0 uM PMID[532996]
NPT35 Others n.a. Activity = 6281.0 umol/g PMID[532996]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC226942 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC96791
1.0 High Similarity NPC470636
0.9783 High Similarity NPC172182
0.9783 High Similarity NPC251182
0.9783 High Similarity NPC262935
0.922 High Similarity NPC111201
0.9189 High Similarity NPC474386
0.9172 High Similarity NPC226644
0.9172 High Similarity NPC37226
0.9172 High Similarity NPC178202
0.9149 High Similarity NPC164697
0.9149 High Similarity NPC289660
0.9149 High Similarity NPC82920
0.9116 High Similarity NPC5871
0.911 High Similarity NPC78335
0.911 High Similarity NPC230713
0.9103 High Similarity NPC135325
0.9097 High Similarity NPC210826
0.9078 High Similarity NPC270913
0.906 High Similarity NPC160015
0.906 High Similarity NPC247677
0.9054 High Similarity NPC213608
0.9054 High Similarity NPC1477
0.9054 High Similarity NPC235333
0.9048 High Similarity NPC170169
0.9034 High Similarity NPC130581
0.9034 High Similarity NPC12148
0.9 High Similarity NPC260902
0.9 High Similarity NPC296957
0.8993 High Similarity NPC297531
0.8993 High Similarity NPC148938
0.8993 High Similarity NPC213936
0.8966 High Similarity NPC51641
0.8966 High Similarity NPC300267
0.8958 High Similarity NPC225884
0.8947 High Similarity NPC472346
0.894 High Similarity NPC476350
0.894 High Similarity NPC40583
0.894 High Similarity NPC476349
0.894 High Similarity NPC244750
0.8933 High Similarity NPC180924
0.8926 High Similarity NPC183874
0.8926 High Similarity NPC472462
0.8919 High Similarity NPC193976
0.8919 High Similarity NPC106372
0.8919 High Similarity NPC58668
0.8919 High Similarity NPC23668
0.8912 High Similarity NPC221868
0.8912 High Similarity NPC39929
0.8912 High Similarity NPC37208
0.8912 High Similarity NPC296030
0.8904 High Similarity NPC17816
0.8897 High Similarity NPC230943
0.8882 High Similarity NPC115432
0.8882 High Similarity NPC260296
0.8874 High Similarity NPC268360
0.8874 High Similarity NPC164110
0.8874 High Similarity NPC96342
0.8874 High Similarity NPC65504
0.8874 High Similarity NPC212967
0.8874 High Similarity NPC246647
0.8867 High Similarity NPC198490
0.8859 High Similarity NPC142308
0.8859 High Similarity NPC207624
0.8859 High Similarity NPC67654
0.8851 High Similarity NPC167576
0.8844 High Similarity NPC272194
0.8828 High Similarity NPC302181
0.8792 High Similarity NPC156244
0.8792 High Similarity NPC115324
0.8776 High Similarity NPC308200
0.8768 High Similarity NPC186628
0.8767 High Similarity NPC155144
0.8759 High Similarity NPC472344
0.8759 High Similarity NPC53192
0.875 High Similarity NPC469818
0.8742 High Similarity NPC99199
0.8733 High Similarity NPC263676
0.8725 High Similarity NPC476509
0.8716 High Similarity NPC145467
0.8716 High Similarity NPC39195
0.871 High Similarity NPC155640
0.8705 High Similarity NPC279566
0.869 High Similarity NPC157497
0.869 High Similarity NPC285659
0.869 High Similarity NPC81337
0.8681 High Similarity NPC240305
0.8675 High Similarity NPC122365
0.8675 High Similarity NPC72370
0.8671 High Similarity NPC255801
0.8671 High Similarity NPC322301
0.8667 High Similarity NPC116604
0.8658 High Similarity NPC317492
0.8658 High Similarity NPC471114
0.8654 High Similarity NPC136641
0.8654 High Similarity NPC204088
0.8654 High Similarity NPC259007
0.8654 High Similarity NPC329215
0.8639 High Similarity NPC271288
0.8639 High Similarity NPC98926
0.8639 High Similarity NPC311144
0.8639 High Similarity NPC326500
0.8636 High Similarity NPC304839
0.8636 High Similarity NPC220582
0.8621 High Similarity NPC477272
0.8621 High Similarity NPC28337
0.8611 High Similarity NPC183639
0.8611 High Similarity NPC474487
0.8611 High Similarity NPC254168
0.8611 High Similarity NPC248995
0.8611 High Similarity NPC199458
0.8611 High Similarity NPC474504
0.8611 High Similarity NPC272844
0.8611 High Similarity NPC470672
0.8611 High Similarity NPC470671
0.8609 High Similarity NPC41326
0.8609 High Similarity NPC253872
0.8601 High Similarity NPC470983
0.8601 High Similarity NPC470982
0.86 High Similarity NPC472406
0.86 High Similarity NPC476185
0.86 High Similarity NPC29777
0.86 High Similarity NPC321896
0.86 High Similarity NPC471115
0.8599 High Similarity NPC323137
0.8591 High Similarity NPC168085
0.859 High Similarity NPC38591
0.859 High Similarity NPC109180
0.859 High Similarity NPC159508
0.8582 High Similarity NPC215875
0.8582 High Similarity NPC15834
0.8581 High Similarity NPC45124
0.8581 High Similarity NPC477955
0.8581 High Similarity NPC74854
0.8581 High Similarity NPC299011
0.8581 High Similarity NPC30655
0.8571 High Similarity NPC9117
0.8571 High Similarity NPC24821
0.8571 High Similarity NPC190637
0.8571 High Similarity NPC112749
0.8571 High Similarity NPC293053
0.8571 High Similarity NPC113770
0.8571 High Similarity NPC212932
0.8571 High Similarity NPC11700
0.8562 High Similarity NPC476508
0.8562 High Similarity NPC74397
0.8562 High Similarity NPC137100
0.8562 High Similarity NPC282300
0.8552 High Similarity NPC55018
0.8552 High Similarity NPC477956
0.8552 High Similarity NPC216978
0.8552 High Similarity NPC220062
0.8552 High Similarity NPC301217
0.8552 High Similarity NPC53181
0.8552 High Similarity NPC241975
0.8552 High Similarity NPC19476
0.8552 High Similarity NPC217186
0.8552 High Similarity NPC96565
0.8552 High Similarity NPC303633
0.8544 High Similarity NPC50394
0.8544 High Similarity NPC286230
0.8544 High Similarity NPC253730
0.8544 High Similarity NPC476459
0.8543 High Similarity NPC290671
0.8542 High Similarity NPC138047
0.8542 High Similarity NPC474624
0.8542 High Similarity NPC62735
0.8542 High Similarity NPC131782
0.8535 High Similarity NPC169471
0.8535 High Similarity NPC37183
0.8531 High Similarity NPC101752
0.8526 High Similarity NPC219861
0.8521 High Similarity NPC16197
0.8514 High Similarity NPC184649
0.8514 High Similarity NPC273538
0.8514 High Similarity NPC224714
0.8514 High Similarity NPC470673
0.8514 High Similarity NPC311741
0.8514 High Similarity NPC470890
0.8514 High Similarity NPC117716
0.8514 High Similarity NPC303185
0.8514 High Similarity NPC196137
0.8514 High Similarity NPC1886
0.8514 High Similarity NPC470674
0.8514 High Similarity NPC234629
0.8514 High Similarity NPC216538
0.8506 High Similarity NPC270044
0.8503 High Similarity NPC473042
0.8503 High Similarity NPC470556
0.8503 High Similarity NPC144499
0.8503 High Similarity NPC200694
0.8497 Intermediate Similarity NPC469934
0.8493 Intermediate Similarity NPC69769
0.8493 Intermediate Similarity NPC241100
0.8493 Intermediate Similarity NPC270883
0.8493 Intermediate Similarity NPC172986
0.8493 Intermediate Similarity NPC159275
0.8493 Intermediate Similarity NPC261227
0.8483 Intermediate Similarity NPC268178
0.8483 Intermediate Similarity NPC201395

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC226942 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9078 High Similarity NPD2800 Approved
0.8521 High Similarity NPD6651 Approved
0.8514 High Similarity NPD4378 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD2344 Approved
0.8389 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD3749 Approved
0.8267 Intermediate Similarity NPD2534 Approved
0.8267 Intermediate Similarity NPD2533 Approved
0.8267 Intermediate Similarity NPD2532 Approved
0.8258 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD2309 Approved
0.8176 Intermediate Similarity NPD1243 Approved
0.8158 Intermediate Similarity NPD920 Approved
0.8113 Intermediate Similarity NPD6959 Discontinued
0.8077 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1240 Approved
0.7987 Intermediate Similarity NPD1549 Phase 2
0.7949 Intermediate Similarity NPD7411 Suspended
0.7908 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD1510 Phase 2
0.7891 Intermediate Similarity NPD1607 Approved
0.7885 Intermediate Similarity NPD4380 Phase 2
0.7862 Intermediate Similarity NPD7768 Phase 2
0.7862 Intermediate Similarity NPD3882 Suspended
0.7853 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD2796 Approved
0.7848 Intermediate Similarity NPD7819 Suspended
0.7848 Intermediate Similarity NPD2801 Approved
0.7843 Intermediate Similarity NPD1511 Approved
0.7826 Intermediate Similarity NPD5494 Approved
0.7812 Intermediate Similarity NPD7075 Discontinued
0.7805 Intermediate Similarity NPD7473 Discontinued
0.7791 Intermediate Similarity NPD3926 Phase 2
0.7785 Intermediate Similarity NPD2799 Discontinued
0.7785 Intermediate Similarity NPD1934 Approved
0.7784 Intermediate Similarity NPD6559 Discontinued
0.7778 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD1512 Approved
0.7736 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD6232 Discontinued
0.7682 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD6801 Discontinued
0.7647 Intermediate Similarity NPD3750 Approved
0.7633 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD5710 Approved
0.7622 Intermediate Similarity NPD5711 Approved
0.7613 Intermediate Similarity NPD6799 Approved
0.7593 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD2296 Approved
0.7561 Intermediate Similarity NPD1247 Approved
0.7547 Intermediate Similarity NPD6599 Discontinued
0.7545 Intermediate Similarity NPD3818 Discontinued
0.753 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD6166 Phase 2
0.753 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD7286 Phase 2
0.75 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7390 Discontinued
0.75 Intermediate Similarity NPD2935 Discontinued
0.7439 Intermediate Similarity NPD919 Approved
0.7434 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD5953 Discontinued
0.7386 Intermediate Similarity NPD6099 Approved
0.7386 Intermediate Similarity NPD6100 Approved
0.7386 Intermediate Similarity NPD1551 Phase 2
0.7383 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD3226 Approved
0.7371 Intermediate Similarity NPD4287 Approved
0.7362 Intermediate Similarity NPD3817 Phase 2
0.7338 Intermediate Similarity NPD1471 Phase 3
0.7338 Intermediate Similarity NPD2346 Discontinued
0.7337 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD3748 Approved
0.7305 Intermediate Similarity NPD7229 Phase 3
0.7301 Intermediate Similarity NPD1465 Phase 2
0.7294 Intermediate Similarity NPD5844 Phase 1
0.7251 Intermediate Similarity NPD7074 Phase 3
0.7248 Intermediate Similarity NPD4908 Phase 1
0.7239 Intermediate Similarity NPD6280 Approved
0.7239 Intermediate Similarity NPD6279 Approved
0.7219 Intermediate Similarity NPD2403 Approved
0.7197 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD7054 Approved
0.7171 Intermediate Similarity NPD943 Approved
0.7167 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD4361 Phase 2
0.7162 Intermediate Similarity NPD1203 Approved
0.7152 Intermediate Similarity NPD3268 Approved
0.7152 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD1729 Discontinued
0.7151 Intermediate Similarity NPD7472 Approved
0.7134 Intermediate Similarity NPD2654 Approved
0.7114 Intermediate Similarity NPD2798 Approved
0.7111 Intermediate Similarity NPD4360 Phase 2
0.7111 Intermediate Similarity NPD4363 Phase 3
0.711 Intermediate Similarity NPD6797 Phase 2
0.7101 Intermediate Similarity NPD6808 Phase 2
0.7089 Intermediate Similarity NPD4628 Phase 3
0.7069 Intermediate Similarity NPD7251 Discontinued
0.7048 Intermediate Similarity NPD5402 Approved
0.7047 Intermediate Similarity NPD2797 Approved
0.7039 Intermediate Similarity NPD3764 Approved
0.7037 Intermediate Similarity NPD5403 Approved
0.7029 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD7808 Phase 3
0.7024 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD5124 Phase 1
0.7011 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1610 Phase 2
0.6988 Remote Similarity NPD5761 Phase 2
0.6988 Remote Similarity NPD5760 Phase 2
0.6974 Remote Similarity NPD4625 Phase 3
0.697 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6966 Remote Similarity NPD8434 Phase 2
0.6959 Remote Similarity NPD1608 Approved
0.6959 Remote Similarity NPD9717 Approved
0.6943 Remote Similarity NPD5404 Approved
0.6943 Remote Similarity NPD5405 Approved
0.6943 Remote Similarity NPD5406 Approved
0.6943 Remote Similarity NPD5408 Approved
0.6933 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6914 Remote Similarity NPD5401 Approved
0.6908 Remote Similarity NPD6832 Phase 2
0.6899 Remote Similarity NPD6004 Phase 3
0.6899 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6899 Remote Similarity NPD6005 Phase 3
0.6899 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6899 Remote Similarity NPD6002 Phase 3
0.6892 Remote Similarity NPD422 Phase 1
0.6879 Remote Similarity NPD7033 Discontinued
0.6875 Remote Similarity NPD7003 Approved
0.6848 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6846 Remote Similarity NPD3972 Approved
0.6842 Remote Similarity NPD7199 Phase 2
0.6826 Remote Similarity NPD37 Approved
0.6824 Remote Similarity NPD6234 Discontinued
0.6821 Remote Similarity NPD3267 Approved
0.6821 Remote Similarity NPD1164 Approved
0.6821 Remote Similarity NPD3266 Approved
0.6813 Remote Similarity NPD3269 Clinical (unspecified phase)
0.681 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6805 Remote Similarity NPD4967 Phase 2
0.6805 Remote Similarity NPD4966 Approved
0.6805 Remote Similarity NPD4965 Approved
0.68 Remote Similarity NPD4749 Approved
0.6798 Remote Similarity NPD8313 Approved
0.6798 Remote Similarity NPD8312 Approved
0.6795 Remote Similarity NPD230 Phase 1
0.6795 Remote Similarity NPD447 Suspended
0.678 Remote Similarity NPD3658 Clinical (unspecified phase)
0.6779 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6772 Remote Similarity NPD4308 Phase 3
0.6772 Remote Similarity NPD651 Clinical (unspecified phase)
0.6763 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6757 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6757 Remote Similarity NPD17 Approved
0.6755 Remote Similarity NPD1876 Approved
0.6748 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6747 Remote Similarity NPD7458 Discontinued
0.6746 Remote Similarity NPD4288 Approved
0.6738 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6735 Remote Similarity NPD1548 Phase 1
0.6732 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6724 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6721 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6711 Remote Similarity NPD1470 Approved
0.6703 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6689 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6688 Remote Similarity NPD6355 Discontinued
0.6688 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6688 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6686 Remote Similarity NPD3446 Phase 1
0.6667 Remote Similarity NPD1201 Approved
0.6648 Remote Similarity NPD3751 Discontinued
0.6646 Remote Similarity NPD2424 Discontinued
0.6645 Remote Similarity NPD3225 Approved
0.6632 Remote Similarity NPD8151 Discontinued
0.6623 Remote Similarity NPD2861 Phase 2
0.6609 Remote Similarity NPD3787 Discontinued
0.6603 Remote Similarity NPD411 Approved
0.6603 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6603 Remote Similarity NPD1296 Phase 2
0.6599 Remote Similarity NPD7340 Approved
0.6592 Remote Similarity NPD6104 Discontinued
0.6588 Remote Similarity NPD8455 Phase 2
0.6566 Remote Similarity NPD5049 Phase 3
0.6554 Remote Similarity NPD7177 Discontinued
0.6554 Remote Similarity NPD7228 Approved
0.6538 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6536 Remote Similarity NPD1283 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data